Fortress Biotech Announces Orphan Drug Designations for CAEL-101 in Amyloidosis
Apr 05, 2017 12:01 pm UTC| Business
NEW YORK, April 05, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Apr 05, 2017 12:01 pm UTC| Business
CARLSBAD, Calif., April 05, 2017 -- MaxLinear, Inc.(NYSE:MXL), a leading provider of integrated radio frequency and mixed-signal integrated circuits for the connected home and wired and wireless infrastructure markets,...
Apr 05, 2017 12:01 pm UTC| Business
CARLSBAD, Calif., April 05, 2017 -- MaxLinear, Inc.(NYSE:MXL), a leading provider of integrated radio frequency and mixed-signal integrated circuits for the connected home and wired and wireless infrastructure markets,...
Apr 05, 2017 12:00 pm UTC| Business
Combining ComPACT DNA electroporation and cellular vaccination led to increased tumor antigen-specific CD8+ T cells, delayed tumor progression and improved overall survival in preclinical models ...
Apr 05, 2017 12:00 pm UTC| Business
SEATTLE, April 05, 2017 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced data highlights from presentations of preclinical data for the Company’s investigational...
Apr 05, 2017 12:00 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., April 05, 2017 -- JAGGAER, producers of the world's most comprehensive Source to Pay (S2P) solutions suite, today announces Gazelle (Release 17.1), reflecting upgrades to its entire product...
H/Cell Energy Appoints Two Board Members
Apr 05, 2017 12:00 pm UTC| Business
FLEMINGTON, N.J., April 05, 2017 -- H/Cell Energy Corporation (OTCQB:HCCC), a company developing clean energy solutions featuring hydrogen energy systems, has announced that effective April 3, 2017, it has appointed...